Results
1 -
10 of
53Pharmacokinetics of S-1, an oral formulation of ftorafur, oxonic acid and 5-chloro-2,4-dihydroxypyridine (molar ratio 1:0.4:1) in patients with solid tumors, Cancer Chemotherapy and Pharmacology Flucytosine Treatment and Resistance Mechanisms, Antimicrobial Drug Resistance Suberoylanilide hydroxamic acid enhances chemosensitivity to 5-fluorouracil in hepatocellular carcinoma via inhibition of thymidylate synthase, Tumor Biology 5-Halogenated Pyrimidines and Their Nucleosides, Antitumor Drug Resistance Comparison of 5-Fluoro-2?-Deoxyuridine and 5-Fluorouracil in the Treatment of Murine Colon Cancer; Effects on Thymidylate Synthase, Purine and Pyrimidine Metabolism in Man VIII Transport and Intracellular Metabolism of Fluorinated Pyrimidines in Cultured Cell Lines, Purine and Pyrimidine Metabolism in Man VI 5-Fluorouracil Plus Thymidine or Leucovorin by Continuous I.V. Infusion in the Treatment of Advanced Colorectal Carcinoma, Clinical Applications of Continuous Infusion Chemotherapy and Concomitant Radiation Therapy Biochemical Modulation as a Guide to Rational Combination Chemotherapy for the Treatment of Cancer, Adrenal and Endocrine Tumors in Children Regulation of Thymidylate Synthase in Human Colon Cancer Cells Treated with 5-Fluorouracil and Interferon-Gamma, Novel Approaches to Selective Treatments of Human Solid Tumors